| Amanda E Stott, FNP-BC | |
|
1350 N 500 E, Logan, UT 84341-2400 | |
| (435) 716-1260 | |
| Not Available |
| Full Name | Amanda E Stott |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 1350 N 500 E, Logan, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083265029 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 282150-4405 (Utah) | Secondary |
| 363L00000X | Nurse Practitioner | 282150-4405 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Logan Regional Hospital | Logan, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Former Senate Majority Leader Bill Frist, who is traveling in East Africa with a U.S. delegation "to study the famine affecting the lives of over 12 million people, many of them children," writes in the Huffington Post's blog, "Huffpost Impact," that the group will assess "what more we as a nation can do."
A University of Toronto scientist has developed a new method for identifying the raw ingredients necessary to build 'biologics', a powerful class of medications that has revolutionized treatment of diseases like rheumatoid arthritis and some cancers.
A new study from University of Illinois at Chicago researchers suggests that more than one-third of U.S. adults may be using prescription medications that have the potential to cause depression or increase the risk of suicide, and that because these medications are common and often have nothing to do with depression, patients and health care providers may be unaware of the risk.
Pervasis Therapeutics, Inc. today announced that it completed the initial closing of a $17 million third round of financing. The proceeds will be used primarily to support the company's ongoing clinical development programs, including PVS-10200, a biologically active therapy designed to reestablish healthy vasculature following common interventions to treat peripheral arterial disease (PAD) and potentially other conditions.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Former Senate Majority Leader Bill Frist, who is traveling in East Africa with a U.S. delegation "to study the famine affecting the lives of over 12 million people, many of them children," writes in the Huffington Post's blog, "Huffpost Impact," that the group will assess "what more we as a nation can do."
A University of Toronto scientist has developed a new method for identifying the raw ingredients necessary to build 'biologics', a powerful class of medications that has revolutionized treatment of diseases like rheumatoid arthritis and some cancers.
A new study from University of Illinois at Chicago researchers suggests that more than one-third of U.S. adults may be using prescription medications that have the potential to cause depression or increase the risk of suicide, and that because these medications are common and often have nothing to do with depression, patients and health care providers may be unaware of the risk.
Pervasis Therapeutics, Inc. today announced that it completed the initial closing of a $17 million third round of financing. The proceeds will be used primarily to support the company's ongoing clinical development programs, including PVS-10200, a biologically active therapy designed to reestablish healthy vasculature following common interventions to treat peripheral arterial disease (PAD) and potentially other conditions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda E Stott, FNP-BC Po Box 27128, Salt Lake City, UT 84127-0128 Ph: () - | Amanda E Stott, FNP-BC 1350 N 500 E, Logan, UT 84341-2400 Ph: (435) 716-1260 |
News Archive
Former Senate Majority Leader Bill Frist, who is traveling in East Africa with a U.S. delegation "to study the famine affecting the lives of over 12 million people, many of them children," writes in the Huffington Post's blog, "Huffpost Impact," that the group will assess "what more we as a nation can do."
A University of Toronto scientist has developed a new method for identifying the raw ingredients necessary to build 'biologics', a powerful class of medications that has revolutionized treatment of diseases like rheumatoid arthritis and some cancers.
A new study from University of Illinois at Chicago researchers suggests that more than one-third of U.S. adults may be using prescription medications that have the potential to cause depression or increase the risk of suicide, and that because these medications are common and often have nothing to do with depression, patients and health care providers may be unaware of the risk.
Pervasis Therapeutics, Inc. today announced that it completed the initial closing of a $17 million third round of financing. The proceeds will be used primarily to support the company's ongoing clinical development programs, including PVS-10200, a biologically active therapy designed to reestablish healthy vasculature following common interventions to treat peripheral arterial disease (PAD) and potentially other conditions.
› Verified 8 days ago